(Q53476543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

phase II clinical trial

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Joong Bae Ahn

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

12

Jae Kyung Roh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

10

Yeul Hong Kim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Jae Heon Jeong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Young Suk Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kyung Hee Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Byoung Yong Shim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Tae Won Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Do Youn Oh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Myung Ah Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Yong Tai Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Dae Young Zang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

21 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1073-1080

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

Cancer in older persons: an international issue in an aging world

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Systemic therapy for metastatic colorectal cancer: current options, current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Therapy for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

The continuum of care: a paradigm for the management of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Systematic review of management of colorectal cancer in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9418-2

Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial

21 January 2018

1 reference

12 December 2020

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

12 December 2020

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel

1 reference

12 December 2020

UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients

1 reference

12 December 2020

Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations

1 reference

12 December 2020

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

12 December 2020

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer

1 reference

12 December 2020

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

12 December 2020

10.1007/S10637-010-9418-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20306116%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference